Zimbabwe has turned down a significant American health deal valued at 367 million US dollars (£272m) spanning five years because of the United States' request for confidential data.
This move was revealed after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "skewed".
A government representative has since clarified that the US was requesting genetic material for research and profit but was unwilling to guarantee the benefits from any future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for continued dialogue to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Context
This rejection comes after a similar situation in Kenya, where a high court suspended a similar health funding agreement after legal challenges were raised about the security of Kenyans' medical information.
After resuming office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and responsibility.
As per statements, Sixteen African countries have so far signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"In essence, our country would provide the basic resources for scientific discovery without any assurance that the end products would be accessible to our population should a future pandemic arise."
Sovereignty and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already set up via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with potential pandemics.
"This system is designed to guarantee that when a nation contributes its information, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."
These objections over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future co-operation could be structured in a manner that respects the independence and interests of both nations."
Health Experts Response
A leading public health body stated it understood the government's concerns, but urged that talks should continue considering a large portion of the nation's HIV programmes depended on international support.
"In cases where specific concerns arise, including those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it commented.
The halted deal highlights the continuing challenges between accepting much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.